Siland, Joylene E. Geelhoed, Bastiaan van Gelder, Isabelle C. van der Harst, Pim Rienstra, Michiel Exclusions for present study. <p>Exclusions for present study.</p> Vascular End-stage Disease;leukocyte telomere length;telomere length quartile;BMI;incident AF;telomere length;AF risk factors;CI;PREVEND cohort Background;polymerase chain reaction-based assay;systolic blood pressure;Telomere length 2017-02-03
    https://plos.figshare.com/articles/figure/Exclusions_for_present_study_/4617481
10.1371/journal.pone.0171545.g001